Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
about
Therapeutic options in peripheral T cell lymphomaAdenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingRomidepsin for the Treatment of Peripheral T-Cell LymphomaRomidepsin for the Treatment of Peripheral T-Cell Lymphoma.Use of class I histone deacetylase inhibitor romidepsin in combination regimensResponses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphomaWhy cure, why now?Targeting histone deacetylases in T-cell lymphoma.A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma.
P2860
Q26748857-CD63DCD4-8921-4806-8664-F4147EEDA11AQ26781643-303ED9EA-4B3B-486B-BFE2-0EF957D3D7F9Q26785732-3EA4310E-9FA8-40B4-825B-D1F11C51CB33Q36064937-70872BB3-58F1-4F01-B61A-B131F4467DF6Q37107439-7031631A-C28A-4303-B93D-A7D546B6B20DQ37609238-F357B9AC-413C-4A25-AFAF-893F0FA709E5Q37627236-49278980-9709-4507-ADDA-7E93F731909AQ38998630-DA72E68A-DE21-4775-B882-A2BF5A20C647Q41556725-42F078EE-1CC0-4443-8B2B-8E4467BB298D
P2860
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
@ast
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
@en
type
label
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
@ast
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
@en
prefLabel
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
@ast
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
@en
P2093
P2860
P356
P1433
P1476
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
@en
P2093
Barbara Balser
Barbara Pro
Bertrand Coiffier
Dolores Caballero
Eugeniusz Baran
Francine Foss
H Miles Prince
Jean Nichols
Julie Wolfson
P2860
P2888
P356
10.1186/2050-7771-2-16
P577
2014-09-08T00:00:00Z